Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer. [electronic resource]
Producer: 20170206Description: 1097-102 p. digitalISSN:- 1432-0843
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Injections, Intravenous
- Lenalidomide
- Male
- Maximum Tolerated Dose
- Melanoma -- drug therapy
- Middle Aged
- Response Evaluation Criteria in Solid Tumors
- Thalidomide -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.